ValueCentric launches ValueTrak Mobile
ValueTrak is a unified data and service platform that enables all participants of the pharmaceutical supply chain to share, analyze and report critical supply chain data such as
Harbour BioMed’s partner Solstice Oncology has raised $225m in funding to advance its lead candidate, porustobart, a neoadjuvant immuno-oncology therapy.